Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

Background: The combination of sofosbuvir (SOF), ribavirin (RBV) and peg-interferon-alfa-2a (peg-IFN-alfa-2a) as well as the combination of SOF and RBV for the treatment of patients infected with hepatitis c virus (HCV) has improved rates of sustained virological response (SVR) considerably in recen...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Steinebrunner, Niels (Autore) , Zimmerer, Thomas (Autore) , Stremmel, Wolfgang (Autore) , Eisenbach, Christoph (Autore) , Antoni, Christoph Helmer (Autore) , Pathil-Warth, Anita (Autore)
Natura:	Article (Journal)
Lingua:	inglese
Pubblicazione:	04 August 2015
In:	BMC gastroenterology Year: 2015, Volume: 15
ISSN:	1471-230X
DOI:	10.1186/s12876-015-0328-9
Accesso online:	Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12876-015-0328-9 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12876-015-0328-9
Note sull'autore:	Niels Steinebrunner, Martin F. Sprinzl, Tim Zimmermann, Marcus A. Wörns, Thomas Zimmerer, Peter R. Galle, Wolfgang Stremmel, Christoph Eisenbach, Kerstin Stein, Christoph Antoni, Jörn M. Schattenberg and Anita Pathil

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort di Steinebrunner, Niels (Autore) , Zimmerer, Thomas (Autore) , Stremmel, Wolfgang (Autore) , Eisenbach, Christoph (Autore) , Antoni, Christoph Helmer (Autore) , Pathil-Warth, Anita (Autore) ,

BioMed Central 2015

Resolving-System, kostenfrei, Volltext

Article (Journal) Book/Monograph Online Resource

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

Documenti analoghi